Results
|
2801.
|
|
|
2802.
|
|
|
2803.
|
|
|
2804.
|
|
|
2805.
|
|
|
2806.
|
|
|
2807.
|
|
|
2808.
|
Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myeloma. [electronic resource] by
- Alsina, Melissa
- Fonseca, Rafael
- Wilson, Edward F
- Belle, A Nelida
- Gerbino, Elvira
- Price-Troska, Tammy
- Overton, Rose M
- Ahmann, Gregory
- Bruzek, Laura M
- Adjei, Alex A
- Kaufmann, Scott H
- Wright, John J
- Sullivan, Daniel
- Djulbegovic, Benjamin
- Cantor, Alan B
- Greipp, Philip R
- Dalton, William S
- Sebti, Saïd M
Producer: 20040617
In:
Blood vol. 103
Availability: No items available.
|
|
2809.
|
|
|
2810.
|
|
|
2811.
|
|
|
2812.
|
|
|
2813.
|
|
|
2814.
|
|
|
2815.
|
|
|
2816.
|
|
|
2817.
|
|
|
2818.
|
The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. [electronic resource] by
- Guenzi, E
- Töpolt, K
- Cornali, E
- Lubeseder-Martellato, C
- Jörg, A
- Matzen, K
- Zietz, C
- Kremmer, E
- Nappi, F
- Schwemmle, M
- Hohenadl, C
- Barillari, G
- Tschachler, E
- Monini, P
- Ensoli, B
- Stürzl, M
Producer: 20011205
In:
The EMBO journal vol. 20
Availability: No items available.
|
|
2819.
|
|
|
2820.
|
|